BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
beryl drugs ltd. stock

BERYL DRUGS LTD. Share Price

36.97 -1.82 (-4.69%)
Dec 13 2024 03:25 PM Pharmaceuticals NSE: BERLDRG

BERYL DRUGS LTD. Share Price Update

As of the latest trading session, BERYL DRUGS LTD. share price is currently at 36.97, which is down by -1.82 from its previous closing. Today, the stock has fluctuated between 36.00 and 43.00. Over the past year, BERYL DRUGS LTD. has achieved a return of 63.48 %. In the last month alone, the return has been 8.13 %. Read More...

BERYL DRUGS LTD. Performance

Day Range

Low36.00 High43.00
38.01

52 Week Range

Low 21.76 High 46.00
38.01

BERYL DRUGS LTD. Share Price

524606

BERLDRG

img img img img
No Data Available

Open Price

40.00

Prev. Close

38.80

Volume (Shares)

48033.00

Total traded value

18.03

Upper Circuit

46.56

Lower Circuit

31.04

Note: The current prices & values are delayed, Login to your account for live updates.

BERYL DRUGS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 19.30
PE Ratio (TTM) 56.73
Book Value / Share 18.29
Beta 0.37
ROE 9.07%
EPS (TTM) 0.67
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.01

BERYL DRUGS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 5.61
Operating Expense 5.53
Net Profit 0.01
Net Profit Margin (%) 0.17
Earnings Per Share (EPS) 0.01
EBITDA 0.56
Effective Tax Rate (%) 90.90
Particulars JUN 2024 (Values in Cr)
Revenue 6.25
Operating Expense 5.79
Net Profit 0.37
Net Profit Margin (%) 5.92
Earnings Per Share (EPS) 0.73
EBITDA 0.99
Effective Tax Rate (%) 26.00
Particulars MAR 2024 (Values in Cr)
Revenue 2.98
Operating Expense 3.63
Net Profit -0.35
Net Profit Margin (%) -11.74
Earnings Per Share (EPS) -0.68
EBITDA 0.03
Effective Tax Rate (%) 19.04
Particulars DEC 2023 (Values in Cr)
Revenue 7.62
Operating Expense 7.28
Net Profit 0.31
Net Profit Margin (%) 4.06
Earnings Per Share (EPS) 0.61
EBITDA 0.80
Effective Tax Rate (%) 18.42
Particulars SEP 2023 (Values in Cr)
Revenue 8.03
Operating Expense 7.76
Net Profit 0.27
Net Profit Margin (%) 3.36
Earnings Per Share (EPS) 0.54
EBITDA 0.72
Effective Tax Rate (%) 15.15
Particulars MAR 2024 (Values in Cr)
Revenue 26.73
Operating Expense 26.11
Net Profit 0.77
Net Profit Margin (%) 2.88
Earnings Per Share (EPS) 1.52
EBITDA 2.67
Effective Tax Rate (%) 23.76
Particulars MAR 2023 (Values in Cr)
Revenue 26.89
Operating Expense 26.18
Net Profit 0.77
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 1.52
EBITDA 2.21
Effective Tax Rate (%) 22.44
Particulars MAR 2022 (Values in Cr)
Revenue 14.60
Operating Expense 15.71
Net Profit -0.66
Net Profit Margin (%) -4.52
Earnings Per Share (EPS) -1.30
EBITDA 0.58
Effective Tax Rate (%) 30.52
Particulars MAR 2021 (Values in Cr)
Revenue 14.09
Operating Expense 14.39
Net Profit 0.24
Net Profit Margin (%) 1.70
Earnings Per Share (EPS) 0.47
EBITDA 2.09
Effective Tax Rate (%) 31.42
Particulars MAR 2020 (Values in Cr)
Revenue 12.82
Operating Expense 12.89
Net Profit 0.05
Net Profit Margin (%) 0.39
Earnings Per Share (EPS) 0.09
EBITDA 1.14
Effective Tax Rate (%) 68.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.52
ROE % 9.07
ROCE % 11.38
Total Debt to Total Equity 0.57
EBITDA Margin 10.33
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.84
ROE % 10.03
ROCE % 11.25
Total Debt to Total Equity 0.64
EBITDA Margin 8.45
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.32
ROE % -8.67
ROCE % -3.72
Total Debt to Total Equity 0.68
EBITDA Margin 4.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.57
ROE % -1.29
ROCE % 2.79
Total Debt to Total Equity 0.67
EBITDA Margin 11.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.97
ROE % 0.66
ROCE % 3.98
Total Debt to Total Equity 0.56
EBITDA Margin 8.89
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 17.48
Total Liabilities 17.48
Total Equity 8.92
Share Outstanding 5071700
Price to Book Ratio 1.67
Return on Assets (%) 4.39
Return on Capital (%) 5.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.57
Total Assets 17.51
Total Liabilities 17.51
Total Equity 8.06
Share Outstanding 5071700
Price to Book Ratio 0.77
Return on Assets (%) 4.37
Return on Capital (%) 6.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.27
Total Assets 17.82
Total Liabilities 17.82
Total Equity 7.29
Share Outstanding 5072000
Price to Book Ratio 0.73
Return on Assets (%) -3.69
Return on Capital (%) -5.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 18.64
Total Liabilities 18.64
Total Equity 7.92
Share Outstanding 5072000
Price to Book Ratio 0.42
Return on Assets (%) 1.28
Return on Capital (%) 1.84
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 16.91
Total Liabilities 16.91
Total Equity 7.62
Share Outstanding 5071700
Price to Book Ratio 0.24
Return on Assets (%) 0.28
Return on Capital (%) 0.39
Particulars MAR 2024 (Values in Cr)
Net Income 1.00
Cash from Operations 1.02
Cash from Investing -1.08
Cash from Financing 0.10
Net change in Cash -0.15
Free Cash Flow 2.37
Particulars MAR 2023 (Values in Cr)
Net Income 0.98
Cash from Operations 2.45
Cash from Investing -1.17
Cash from Financing -1.20
Net change in Cash 0.01
Free Cash Flow 4.01
Particulars MAR 2022 (Values in Cr)
Net Income -0.95
Cash from Operations -0.19
Cash from Investing 0.53
Cash from Financing -0.43
Net change in Cash -0.18
Free Cash Flow 0.22
Particulars MAR 2021 (Values in Cr)
Net Income 0.34
Cash from Operations 0.36
Cash from Investing 0.25
Cash from Financing -0.53
Net change in Cash 0.05
Free Cash Flow 1.41
Particulars MAR 2020 (Values in Cr)
Net Income 0.15
Cash from Operations 0.33
Cash from Investing -1.55
Cash from Financing 1.66
Net change in Cash 0.29
Free Cash Flow 2.20
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2254.45 47.63 22.83 38191.74 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 36.70
  • 26 Days 35.40
  • 10 Days 35.80
  • 50 Days 36.50
  • 12 Days 35.50
  • 100 Days 35.00
  • 20 Days 35.00
  • 200 Days 42.00
37.52
PIVOT
First Resistance 41.28
Second Resistance 43.75
Third Resistance 47.51
First Support 35.05
Second Support 31.29
Third Support 28.82
RSI 60.17
MACD 0.06
Commodity Channel Index (CCI) 287.13
ADX 20.48
Williams % R -46.64

Over 1 Month

down

8.13

Over 3 Months

down

-2.18

Over 6 Months

down

6.02

Over 1 Year

down

63.48

Over 3 Years

down

43.17

Over 5 Years

down

51.57

BERYL DRUGS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BERYL DRUGS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
73.61
Promoter Holdings
26.38
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sanjay Sethi Shareholding of Promoter and Promoter Group 551800.0 10.88
Sudhir Sethi Shareholding of Promoter and Promoter Group 438504.0 8.65
Sangita Sethi Shareholding of Promoter and Promoter Group 191935.0 3.78
Soniya Sethi Shareholding of Promoter and Promoter Group 155896.0 3.07
Samir Narendra Gupta Public Shareholding 139377.0 2.75
Narendrakumar Bhagwandas Gupta Public Shareholding 123689.0 2.44
Mayank Siyal Public Shareholding 104865.0 2.07
Jinesh Joseph Public Shareholding 84796.0 1.67
Punjabhai Keshavbhai Jadeja Public Shareholding 62511.0 1.23
R. B. Vijay Public Shareholding 60250.0 1.19
Simimon Kallupurackal Joby Public Shareholding 53335.0 1.05

BERYL DRUGS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BERYL DRUGS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BERYL DRUGS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Beryl Drugs Ltd?

Answer Field

The share price of Beryl Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 38.01.

What is the Market Cap of Beryl Drugs Ltd?

Answer Field

The market cap of Beryl Drugs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 19.30 Cr. as of now.

What is the 52 Week High and Low of Beryl Drugs Ltd?

Answer Field

The 52 Week High and Low of Beryl Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 46.00 and ₹ 21.76.

How to Buy Beryl Drugs Ltd share?

Answer Field

You can trade in Beryl Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Beryl Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 63.48%.

What is the Current Share Price of Beryl Drugs Ltd?

Answer Field

Beryl Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 38.01 as on Dec 13 2024 03:25 PM.

What is the Market Cap of Beryl Drugs Ltd Share?

Answer Field

The market cap of Beryl Drugs Ltd for NSE ₹ 0.0 & for BSE ₹ 19.30 as on Dec 13 2024 03:25 PM.

What is the P/E Ratio of Beryl Drugs Ltd Share?

Answer Field

As on Dec 13 2024 03:25 PM the price-to-earnings (PE) ratio for Beryl Drugs Ltd share is 56.73.

What is the PB ratio of Beryl Drugs Ltd Share?

Answer Field

As on Dec 13 2024 03:25 PM, the price-to-book (PB) ratio for Beryl Drugs Ltd share is 18.29.

How to Buy Beryl Drugs Ltd Share?

Answer Field

You can trade in Beryl Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Beryl Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Beryl Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Beryl Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader